These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
91 related articles for article (PubMed ID: 1384093)
1. Replication of human immunodeficiency virus in HL-60 cells. Semmel M; Macho A; Morozov V; Coulaud D; Alileche A; Plaisance S; Aguilar J; Jasmin C Res Virol; 1992; 143(4):249-58. PubMed ID: 1384093 [TBL] [Abstract][Full Text] [Related]
2. The human immunodeficiency virus-1 nef gene product: a positive factor for viral infection and replication in primary lymphocytes and macrophages. Miller MD; Warmerdam MT; Gaston I; Greene WC; Feinberg MB J Exp Med; 1994 Jan; 179(1):101-13. PubMed ID: 8270859 [TBL] [Abstract][Full Text] [Related]
3. Human immunodeficiency virus infection of T cells and monocytes proceeds via receptor-mediated endocytosis. Pauza CD; Price TM J Cell Biol; 1988 Sep; 107(3):959-68. PubMed ID: 3262112 [TBL] [Abstract][Full Text] [Related]
4. Inhibition of human immunodeficiency virus (HIV) type 1 multiplication by an avian cellular factor. Semmel M; Alileche A; Coulaud D; Aguilar J; Krief P; Jasmin C Arch Virol; 1992; 123(3-4):309-21. PubMed ID: 1314050 [TBL] [Abstract][Full Text] [Related]
5. Human T-lymphoblastoid cells selected for growth in serum-free medium provide new tools for study of HIV replication and cytopathogenicity. Yahi N; Fantini J; Baghdiguian S; Chermann JC J Virol Methods; 1991; 34(2):193-207. PubMed ID: 1725173 [TBL] [Abstract][Full Text] [Related]
6. The monoclonal CD4 antibody M-T413 inhibits cellular infection with human immunodeficiency virus after viral attachment to the cell membrane: an approach to postexposure prophylaxis. Rieber EP; Federle C; Reiter C; Krauss S; Gürtler L; Eberle J; Deinhardt F; Riethmüller G Proc Natl Acad Sci U S A; 1992 Nov; 89(22):10792-6. PubMed ID: 1438278 [TBL] [Abstract][Full Text] [Related]
7. Analysis of long-term viral expression in CEM cells persistently infected with non syncytium-inducing HIV-1 strains. Yelle J; Morisset R; Thibodeau L Arch Virol; 1994; 139(1-2):155-72. PubMed ID: 7826207 [TBL] [Abstract][Full Text] [Related]
8. Cell-to-cell spread of HIV-1 occurs within minutes and may not involve the participation of virus particles. Sato H; Orenstein J; Dimitrov D; Martin M Virology; 1992 Feb; 186(2):712-24. PubMed ID: 1370739 [TBL] [Abstract][Full Text] [Related]
9. High level of surface CD4 prevents stable human immunodeficiency virus infection of T-cell transfectants. Marshall WL; Diamond DC; Kowalski MM; Finberg RW J Virol; 1992 Sep; 66(9):5492-9. PubMed ID: 1501285 [TBL] [Abstract][Full Text] [Related]
10. Human immunodeficiency virus infection studied in CD4-expressing human-murine T-cell hybrids. Tersmette M; van Dongen JJ; Clapham PR; de Goede RE; Wolvers-Tettero IL; Geurts van Kessel A; Huisman JG; Weiss RA; Miedema F Virology; 1989 Feb; 168(2):267-73. PubMed ID: 2464872 [TBL] [Abstract][Full Text] [Related]
11. Human immunodeficiency virus type 2 vpx protein augments viral infectivity. Kappes JC; Conway JA; Lee SW; Shaw GM; Hahn BH Virology; 1991 Sep; 184(1):197-209. PubMed ID: 1714662 [TBL] [Abstract][Full Text] [Related]
12. Variants selected by treatment of human immunodeficiency virus-infected cells with an immunotoxin. Pincus SH; Wehrly K; Tschachler E; Hayes SF; Buller RS; Reitz M J Exp Med; 1990 Sep; 172(3):745-57. PubMed ID: 1696955 [TBL] [Abstract][Full Text] [Related]
13. Study of viral replication in HIV-1-infected CEM T-cell subclones which are reduced in their ability to form syncytia. Gruber MF; Hewlett IK; Simms T; Vujcic L; Manischewitz J; Golding H AIDS Res Hum Retroviruses; 1992 Jun; 8(6):1139-46. PubMed ID: 1380260 [TBL] [Abstract][Full Text] [Related]
14. Persistent infection of MT-4 cells by human immunodeficiency virus type 1 becomes increasingly likely with in vitro serial passage of wild-type but not nef mutant virus. Nishino Y; Nakaya T; Fujinaga K; Kishi M; Azuma I; Ikuta K J Gen Virol; 1994 Sep; 75 ( Pt 9)():2241-51. PubMed ID: 7521392 [TBL] [Abstract][Full Text] [Related]
15. Glycosylphosphatidylinositol-anchored CD4 supports human immunodeficiency virus type 1 replication, but not cytopathic effect, in T-cell transfectants. Marshall WL; Mittler ES; Avery P; Lawrence JP; Finberg RW J Virol; 1994 Jun; 68(6):4039-42. PubMed ID: 8189539 [TBL] [Abstract][Full Text] [Related]
16. The ratio of defective HIV-1 particles to replication-competent infectious virions. Bourinbaiar AS Acta Virol; 1994 Feb; 38(1):59-61. PubMed ID: 7520666 [TBL] [Abstract][Full Text] [Related]
17. Constitutive expression of chimeric neo-Rev response element transcripts suppresses HIV-1 replication in human CD4+ T lymphocytes. Bevec D; Volc-Platzer B; Zimmermann K; Dobrovnik M; Hauber J; Veres G; Böhnlein E Hum Gene Ther; 1994 Feb; 5(2):193-201. PubMed ID: 8186299 [TBL] [Abstract][Full Text] [Related]
18. Inhibition of human immunodeficiency virus replication in a human T cell line by antisense RNA expressed in the cell. Gyotoku J; el-Farrash MA; Fujimoto S; Germeraad WT; Watanabe Y; Teshigawara K; Harada S; Katsura Y Virus Genes; 1991 Jul; 5(3):189-202. PubMed ID: 1722929 [TBL] [Abstract][Full Text] [Related]
19. Factors underlying spontaneous inactivation and susceptibility to neutralization of human immunodeficiency virus. Layne SP; Merges MJ; Dembo M; Spouge JL; Conley SR; Moore JP; Raina JL; Renz H; Gelderblom HR; Nara PL Virology; 1992 Aug; 189(2):695-714. PubMed ID: 1386485 [TBL] [Abstract][Full Text] [Related]
20. A virion-specific inhibitory molecule with therapeutic potential for human immunodeficiency virus type 1. Matsuda Z; Yu X; Yu QC; Lee TH; Essex M Proc Natl Acad Sci U S A; 1993 Apr; 90(8):3544-8. PubMed ID: 7682710 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]